Coverage
-
April 28, 2022
A New York federal judge has dismissed the majority of the claims in a suit alleging former top executives at biotech company MabVax Therapeutics hid information to dupe investors out of millions as the company headed for bankruptcy.
1 other articles on this case.
View all »